Rare diseases
Investigational molecules
Locations
Back to France587 clinical trials in Vandoeuvre Les Nancy, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
FranceA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
FranceA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
FranceStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
FranceA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
FranceA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
FranceA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
FranceA study testing duvakitug for patients with moderately to severely active ulcerative colitis
FranceStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
FranceStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
FranceStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
FranceStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for various cancer types, including head and neck squamous cell carcinoma, multiple myeloma, and prostate cancer. Studies evaluate new therapeutic approaches and diagnostic methods.
Several trials investigate novel drug combinations and targeted therapies for improving patient outcomes.
Comprehensive research into inflammatory bowel diseases, particularly Crohn's disease and ulcerative colitis. Studies explore innovative treatments including microbiota transplantation and new biological therapies.
Trials aim to develop more effective maintenance therapies and improve quality of life for patients.
Groundbreaking research in multiple sclerosis treatment, including both progressive and relapsing forms. Studies evaluate new therapeutic approaches and disease progression markers.
Focus on developing innovative treatments for better management of neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
